CRC Transregio 221Projects

Project B01

 

Therapeutic targeting of T-follicular cells in GvHD

Site: Würzburg, Erlangen
Principal Investigator: apl. Prof. Friederike Berberich-Siebelt, PD Dr. med. Silvia Spörl

Project B02

 

Targeting of TNFR2 and related molecules to separate GvHD from the GvL effect

Site: Würzburg
Principal Investigator: Prof. Dr. rer. nat. Harald Wajant

Project B03

 

Generation, molecular characteristics and effector mechanisms of CSF2+-T-cells in graft-versus-host disease.

Site: Erlangen 
Principal Investigator: Prof. Dr. med. Kai Hildner

Project B04

 

Aldehyde dehydrogenase 3A2 (ALDH3A2) as a novel regulator of inflammation and fibrotic tissue remodeling in sclerodermatous chronic graft-versus-host-disease

Site: Erlangen 
Principal Investigators: Prof. Dr. med. Jörg Distler, PD Dr. med. Regina Jitschin, PhD

Project B07

 

GvHD therapy with in vitro expanded donor regulatory T cells.

Site: Regensburg
Principal Investigators: PD Dr. rer. nat. Petra Hoffmann, Prof. Dr. rer. nat. Michael Rehli, Prof. Dr. med. Matthias Edinger

Project B08

 

Harnessing tissue homeostasis-promoting functions of specialized regulatory T cells in graft-versus-host disease.

Site: Regensburg
Principal Investigator: Prof. Dr. med. Markus Feuerer

Project B09

 

Non-classical monocyte-derived intestinal myeloid cells in allo-HSCT - Biology and therapeutic applications.

Site: Würzburg
Principal Investigator: Prof. Dr. med. Dr. med. univ. Andreas Beilhack, Dr. rer. nat. Mercedes Gomez de Agüero

Project B10

 

Dysregulation of the B-lymphocyte compartments leading to chronic GvHD

Sites: Erlangen & Regensburg
Principal Investigators: Prof. Dr. rer. nat. Thomas Winkler, Dr. med. Julia Winkler, Prof. Dr. med. Daniel Wolff

Project B11

 

Targeting the reciprocal interaction of GvHD and atherosclerosis after allogeneic HSCT.

Site: Würzburg
Principal Investigators: Prof. Dr. med. Alma Zernecke, Prof. Dr. med. Dr. med. univ. Andreas Beilhack

Project B12

 

Regulation of the immune balance during allogeneic hematopoietic stem cell transplantation by vitamin D3.

Sites: Regensburg & Erlangen
Principal Investigators: Prof. Dr. rer. nat. Marina Kreutz, PD Dr. rer. nat. Heiko Bruns

Project B13

 

Enterococci in allogeneic stem cell transplantation – indicators of loss of diversity or true GvHD pathogens.

Site: Regensburg
Principal Investigators: PD Dr. med. Daniela Weber, Prof. Dr. med. Dr. rer. nat. André Gessner, Prof. Dr. med. Ernst Holler